Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Kane

Plastic Surgery New York, NY Medical Doctor

NPI 1386723997 CMS profile 334799

630 Park Ave, New York, NY 10021

Open in the dashboard

General payments

$250,406

153 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$293,868 paid to institutions, not to them · program year 2021

Through program year 2025, Michael Kane of New York, NY is reported in the CMS Open Payments database as having received $250,406 across 153 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $293,868 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,671 21
2024 General $154 3
2023 General $26,457 23
2022 General $28,988 19
2021 General $29,938 16
2020 General $32,949 6
2019 General $112,248 65

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Kane
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Michael Kane were reported at $19,671. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Michael Kane Plastic Surgery median Middle half National median
2019 $112,248 $371 $122–$1,483 $163
2020 $32,949 $158 $52–$438 $114
2021 $29,938 $249 $87–$752 $132
2022 $28,988 $274 $102–$793 $149
2023 $26,457 $299 $113–$891 $160
2024 $154 $361 $124–$1,062 $164
2025 $19,671 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $88,469 45 payments
  2. Merz North America, Inc. $59,704 29 payments
  3. AbbVie, Inc. $53,163 40 payments
  4. Galderma Laboratories, L.P. $30,446 23 payments
  5. Endo Pharmaceuticals Inc. $11,626 5 payments
  6. Ipsen Innovation $6,723 6 payments
  7. Revance Therapeutics, Inc. $254 4 payments
  8. Insulet Corporation $22 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $202,258 25 payments
  2. Travel and Lodging $42,821 47 payments
  3. Food and Beverage $5,327 81 payments
Products named General payments · program years 2019–2025
  1. Xeomin $59,661 28 payments
  2. BOTOX COSMETIC $52,877 23 payments
  3. BOTOX $52,221 28 payments
  4. DYSPORT Neurology $6,723 6 payments
  5. DAXXIFY $254 4 payments
  6. NATRELLE $215 4 payments
  7. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $174 2 payments
  8. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $96 1 payment
  9. DYSPORT $30 1 payment
  10. Omnipod $22 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

153 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record